Andrea has two MSc in Physical Engineering and Electronic Engineering and was awarded his PhD in Applied Physics from Eindhoven (NL) University of Technology. He is author of ten peer-reviewed publications and co-inventor in eight international patents. Andrea has been working in the field of in vitro diagnostics for the last 8 years. Some of his past endavours encompass development of opto-magnetic nanotechnologies for biomarker detection in complex matrixes at Philips Research (NL) as part of the team that developed the Magnotech core technology implemented on the Philips Minicare system. After relocation to Australia, he joined the Institute for Molecular Bioscience, at the University of Queensland to lead four projects on biosensing. Dr Ranzoni was appointed to Head of BioEngineering in August 2015 and has since developed biofunctional highly fluorescent nanoparticles with engineered surface properties for minimal non-specific interactions which is used across a number of Ellume platforms. Dr Ranzoni currently leads the ellume·lab development program.   BACK  

 Andrea has two MSc in Physical Engineering and Electronic Engineering and was awarded his PhD in Applied Physics from Eindhoven (NL) University of Technology. He is author of ten peer-reviewed publications and co-inventor in eight international patents. Andrea has been working in the field of in vitro diagnostics for the last 8 years. Some of his past endavours encompass development of opto-magnetic nanotechnologies for biomarker detection in complex matrixes at Philips Research (NL) as part of the team that developed the Magnotech core technology implemented on the Philips Minicare system. After relocation to Australia, he joined the Institute for Molecular Bioscience, at the University of Queensland to lead four projects on biosensing. Dr Ranzoni was appointed to Head of BioEngineering in August 2015 and has since developed biofunctional highly fluorescent nanoparticles with engineered surface properties for minimal non-specific interactions which is used across a number of Ellume platforms. Dr Ranzoni currently leads the ellume·lab development program.   BACK